by Bruce Sylvester: Treating high-risk, acute coronary syndrome (ACS) patients with both a stain and ezetimibe enhances prevention of heart attacks and strokes, researchers reported on Nov. 17,… read more.
by Bruce Sylvester: Treatment of recurrent Clostridium difficile infection with oral, frozen and encapsulated fecal material from unrelated donors has resulted in a 90 percent rate of resolution… read more.
by Esther Drain: A sub-group analysis of the CRYSTAL study. In the CRYSTAL study, adding cetuximab (cet) to first-line chemotherapy (CT) improved clinical outcome in patients (pts) with RAS… read more.
by Denys Wheatley: There is some irony in the title of this symposium because medicine should always be as precise as it can, and advances are expected that… read more.
Professor Lenz gives his opinions following the presentation of data from FIRE 3 and CALGB/SWOG 80405 at ESMO 2014.
Engagement of patients and understanding of early death in this group by Denys Wheatley. (1) When and why do teenage and young adult oncology patients die early in… read more.
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley. On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.
Click ‘Read More’ for the new data delegate views on whether early tumour shrinkage is now an accepted marker in mCRC.
by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.
by Denys Wheatley: A large cohort study of Regorafenib (REG) in the real-life setting in patients previously treated for metastatic colorectal cancer
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
